• Chief Healthcare ExecutiveChief Healthcare Executive
  • Formulary WatchFormulary Watch
  • Managed Healthcare Executive
  • Medical EconomicsMedical Economics
Managed Healthcare Executive
Managed Healthcare Executive
Resource Centers
View MoreAsthmaAtrial FibrillationBiosimilarsBlood CancerCovid-19DermatologyDigital HealthEye CareHemophiliaHIVLiver DiseaseMultiple SclerosisNeonatal CarePost-Acute CarePrescription Digital TherapeuticsRespiratory ConditionsSleep DisordersSubstance Use DisorderType II InflammationUlcerative ColitisVaccines
Spotlight
AMCP AnnualAsembia’s 2022 Specialty Pharmacy SummitAMCP NexusExamining Evolving Treatment Paradigms in the Hemophilia B Space Payer Provider Perspectives: Prescription Digital Therapeutics: Reimagining Care in Behavior-Driven ConditionsPBMI National ConferenceUnbranded Biologics: An Overview
Business
View MoreBusiness StrategyChronic DiseaseConsumersDrug CostsDrug PipelineFormularyHealth ManagementHealth/Disease StrategyHospitals & ProvidersIndustry AnalysisPharmacyPolitics and PolicyPractice ManagementReimbursementTechnology
News
Media
Expert Interviews
K-Cast
Medical World News
Podcasts
Population Health Perspectives
ConferencesPartners
Publications
MHE Publication
Supplements And Featured Publications
Events
Virtual Events
CME/CE
Resources
PBM Leaders
Sponsored
Sponsored Content
Surveys
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations

© 2023 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.

Advertisement
Resource CentersSee All >
  • Asthma
  • Atrial Fibrillation
  • Biosimilars
  • Blood Cancer
  • Covid-19
  • Dermatology
  • Digital Health
  • Eye Care
  • Hemophilia
  • HIV
  • Liver Disease
  • Multiple Sclerosis
  • Neonatal Care
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Respiratory Conditions
  • Sleep Disorders
  • Substance Use Disorder
  • Type II Inflammation
  • Ulcerative Colitis
  • Vaccines
Spotlight
  • AMCP Annual
  • Asembia’s 2022 Specialty Pharmacy Summit
  • AMCP Nexus
  • Examining Evolving Treatment Paradigms in the Hemophilia B Space
  • Payer Provider Perspectives: Prescription Digital Therapeutics: Reimagining Care in Behavior-Driven Conditions
  • PBMI National Conference
  • Unbranded Biologics: An Overview
BusinessSee All >
  • Business Strategy
  • Chronic Disease
  • Consumers
  • Drug Costs
  • Drug Pipeline
  • Formulary
  • Health Management
  • Health/Disease Strategy
  • Hospitals & Providers
  • Industry Analysis
  • Pharmacy
  • Politics and Policy
  • Practice Management
  • Reimbursement
  • Technology
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.

Obstetrics-Gynecology & Women's Health

  1. home
  2. clinical
  3. obstetrics-gynecology-womens-health
 

Individualizing UF Therapy

May 06, 2022

Drs Al-Hendy and Lopes conclude with final thoughts on GnRH receptor antagonists, relugolix and elagolix, changing the UF treatment landscape.

Addressing Unmet Needs in UF

May 06, 2022

Dr Al-Hendy discusses what it takes to individualize UF treatment for each patient.

Unmet Needs for UF Treatment

April 29, 2022

Drs Lopes and Al-Hendy describe the unmet needs they see when treating patients with UF.

Healthcare Disparities in Women’s Reproductive Health

April 29, 2022

Dr Maria Lopes provides an overview of common disparities seen when treating and maintaining women’s reproductive health and how these can be minimized.

Managing UF Treatment

April 22, 2022

Dr Lopes discusses the typical payer challenges with managing UF treatment, including pain management.

GnRH Receptor Antagonists in UF

April 22, 2022

Dr Al-Hendy highlights the oral GnRH receptor antagonists as first-line therapy for UF.

UF Treatment Goals

April 18, 2022

Dr Al-Hendy briefly explains how he determines treatment goals during initial workups for patients with UF.

A Changing Treatment Paradigm in UF

April 18, 2022

Dr Ayman Al-Hendy details the shift from surgical options to medical therapy for patients with UF.

UF Risk Factors

April 08, 2022

Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP, elaborates on risk factors for the development of UF.

The Economic Burden of UF

April 08, 2022

Maria Lopes, MD, discusses the economic burden of UF from a payer’s perspective, explaining direct and indirect costs associated with the condition.

Advertisement
Advertisement